- £55.17m
- £50.87m
- £4.00m
REG - Creo Medical Group - Result of AGM
AnnouncementREG - Creo Medical Group - AGM Statement and Directorate Changes
AnnouncementRCS - Creo Medical Group - U.S. FDA clearance for SpydrBlade™ Flex
AnnouncementREG - Creo Medical Group - Director/PDMR Shareholding
AnnouncementREG - Creo Medical Group - Posting of AR&R and Notice of AGM
AnnouncementREG - Creo Medical Group - US Reimbursement milestone for Speedboat procedure
AnnouncementREG - Creo Medical Group M&G PLC - Holding(s) in Company
AnnouncementREG - Creo Medical Group M&G PLC - Holding(s) in Company
AnnouncementREG - Creo Medical Group - Directorate changes
AnnouncementREG - Creo Medical Group - Final Results
AnnouncementREG - Creo Medical Group - Notice of investor presentations
AnnouncementREG - Creo Medical Group - Notice of Results
AnnouncementREG - Creo Medical Group - Holding(s) in Company
AnnouncementREG - Creo Medical Group - Grant of Options
AnnouncementRCS - Creo Medical Group - UK & EU Commercial launch of SpydrBlade™ Flex
AnnouncementREG - Creo Medical Group - Appointment of Nominated Adviser and sole Broker
AnnouncementREG - Creo Medical Group - FY24 Trading Update
AnnouncementREG - Creo Medical Group - Completion of sale of 51% interest in subsidiary
AnnouncementRCS - Creo Medical Group - First Welsh adopter of Speedboat® technology
Announcement